Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplantation Recipient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03659773
What this trial is testing

Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
VaccinationHematopoietic Stem Cells
Hospices Civils de Lyon 152
Not applicableLooking for participantsNCT07341698
What this trial is testing

Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Al-logeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Rigshospitalet, Denmark 110
Not applicableStudy completedNCT05789615
What this trial is testing

Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China

Who this might be right for
CMV InfectionHematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 200
Testing effectiveness (Phase 2)Study completedNCT03613727
What this trial is testing

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Lymphoid LeukemiaMyeloid LeukemiaMonocytic Leukemia+1 more
Virginia Commonwealth University 61
Testing effectiveness (Phase 2)Looking for participantsNCT07214688
What this trial is testing

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Who this might be right for
Allogeneic Stem Cell Transplant Recipient
Hackensack Meridian Health 209
Early research (Phase 1)Study completedNCT02083250
What this trial is testing

Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionAllogeneic Hematopoietic Stem Cell Transplantation Recipient+4 more
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)Looking for participantsNCT07771855
What this trial is testing

Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation Recipients

Who this might be right for
Bronchiolitis Obliterans Syndrome (BOS)HSCTBronchial Disease
Hopital Foch 36
Testing effectiveness (Phase 2)Study completedNCT04263597
What this trial is testing

Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients

Who this might be right for
Hematopoietic Stem Cell Transplant
Children's Hospital Medical Center, Cincinnati 70
Not applicableUnknownNCT04281797
What this trial is testing

Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients

Who this might be right for
Transplantation InfectionKidney Transplant; ComplicationsStem Cell Transplant Complications+2 more
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 90
Not applicableStudy completedNCT03719092
What this trial is testing

High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Ohio State University Comprehensive Cancer Center 62
Testing effectiveness (Phase 2)Study completedNCT00006184
What this trial is testing

Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT02220985
What this trial is testing

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia of Ambiguous Lineage+20 more
Fred Hutchinson Cancer Center 84
Testing effectiveness (Phase 2)Study completedNCT04339062
What this trial is testing

Cemiplimab in AlloSCT/SOT Recipients With CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaAdvanced Cancer
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)WithdrawnNCT03851081
What this trial is testing

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientBlasts 5 Percent or More of Bone Marrow Nucleated CellsBlasts 5 Percent or More of Peripheral Blood White Cells+5 more
Roswell Park Cancer Institute
Not applicableLooking for participantsNCT04689750
What this trial is testing

Donor CHIP and Allogeneic HSCT Outcome

Who this might be right for
Clonal Hematopoiesis
The University of Hong Kong 850
Very early researchLooking for participantsNCT03665675
What this trial is testing

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirusDonor+2 more
Sumithira Vasu 20
Large-scale testing (Phase 3)Study completedNCT03565900
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 277
Early research (Phase 1)Temporarily pausedNCT03494569
What this trial is testing

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia+5 more
City of Hope Medical Center 36
Not applicableStudy completedNCT07049536
What this trial is testing

Physical Fitness of Allogeneic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
Istinye University 17
Testing effectiveness (Phase 2)Study completedNCT02210065
What this trial is testing

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 6
Next Page